Investors.soterahealth.com
Investor Relations Sotera Health
WebSotera Health Reports First-Quarter 2024 Results. Q1 2024 net revenues increased 12.5% to $248 million, compared to Q1 2023 Q1 2024 net income of $6 million or $0.02 per diluted share, comp ared to net income of $3 million or $0.01 per diluted share in Q1 2023 Q1 2024 Adjusted EBITDA ( 1 ) increased 13.7% to $112 million, compared to Q1 2023 Q1.
Actived: 5 days ago
Sotera Health Reports Fourth-Quarter and Full-Year 2021 Results
WebQ4 2021 net revenues increased 11% to $241 million, compared to Q4 2020 Q4 2021 net income of $36 million or $0.13 per diluted share, compared to a net loss of $44 million or $(0.17) per diluted share in Q4 2020 Q4 2021 Adjusted EBITDA increased 10% to $125 million, compared to Q4 2020 Q4 2021
Sotera Health Reports Third-Quarter and Year-to-Date 2021 …
WebThird-quarter 2021 net revenues increased 13.1% to $226 million, compared with $200 million in the same period a year ago. Third-quarter 2021 net income attributable to Sotera Health (“net income”) was $27 million, or $0.10 per diluted share, compared with net income of $0.01 million, or $0.00 per diluted share in the third quarter of 2020.
Sotera Health Reports Fourth-Quarter and Full-Year 2022 Results
WebQ4 2022 net revenues increased 4% to $252 million , compared to Q4 2021 Q4 2022 net loss of $320 million or $1.14 per diluted share, which includes a $408 million legal reserve recorded in Q4 2022, compared to net income of $36 million or $0.13 per diluted share in Q4 2021 Q4 2022 Adjusted EBITDA
Sotera Health Reports First-Quarter 2021 Results Sotera Health
WebFirst-quarter 2021 net revenues increased 13% to $212 million, compared with $188 million in the first-quarter a year ago. Net income attributable to Sotera Health (“net income”) was $11 million, or $0.04 per diluted share, compared with a net loss of $2 million, or $0.01 per diluted share in the first-quarter 2020.
Sotera Health Reports Second-Quarter and First-Half 2021 Results
WebIncludes depreciation of Co-60 held at gamma irradiation sites. Represents non-cash share-based compensation expense. Represents the effects of (i) fluctuations in foreign currency exchange rates, primarily related to remeasurement of intercompany loans denominated in currencies other than subsidiaries’ functional currencies, and (ii) non …
Sotera Health Reports Third-Quarter and Year-to-Date 2022 …
WebThird-quarter 2022 net revenues increased 10.0% to $249 million, compared with $226 million in the same period a year ago. Net revenues increased 13.2% on a constant currency basis. Third-quarter 2022 net income attributable to Sotera Health (“net income”) was $25 million, or $0.09 per diluted share, compared with net income of $27 million
Jonathan Lyons Management Sotera Health
WebJonathan (Jon) Lyons has served as senior vice president and chief financial officer of Sotera Health since June 2023. Prior to joining Sotera Health, Mr. Lyons was most recently the vice president, corporate FP&A for Owens Corning. Prior to this role, Mr. Lyons was vice president and finance leader for Owens Corning’s Insulation business and
Sotera Health Reports First-Quarter 2024 Results Sotera Health
WebNelson Labs. For first-quarter 2024, net revenues were $58 million, an increase of 10.8% compared to the first quarter a year ago. Segment income increased 8.8% to $15 million. Net revenue and segment income growth for the first-quarter 2024 were primarily driven by volume and mix improvements as well as favorable pricing.
Sotera Health Reports Third-Quarter and Year-to-Date 2023 …
WebThird-quarter 2023 net revenues increased 5.8% to $263 million, compared with $249 million in the third-quarter 2022. Net loss was $14 million, or $0.05 per diluted share, including a previously disclosed legal settlement of $35 million. This compares with net income of $25 million, or $0.09 per diluted share in the third-quarter of 2022.
Sotera Health Reports Fourth-Quarter and Full-Year 2023 Results
Web2023 net revenues increased 4.5% to $1.05 billion, compared to 2022; 2023 net income of $51 million or $0.18 per diluted share; 2023 Adjusted EBITDA (1) increased 4.3% to $528 million; 2023 Adjusted EPS (1) decreased $0.15 to $0.81 per diluted share; Full-year 2024 outlook of 4.0% - 6.0% growth for Net Revenues and Adjusted EBITDA; …
News Sotera Health
WebCLEVELAND, Feb. 28, 2024 (GLOBE NEWSWIRE) -- Sotera Health Company (Nasdaq: SHC) (the “Company”) today announced the pricing of its secondary offering (the “Offering”) of 25,000,000 shares of its common stock, par value $0.01 per share, at a price to the public of $14.75 per share. 27 Feb, '2024. Sotera Health Announces Secondary
News Release Details
WebAcquisition strengthens Nelson Labs’ outsourced testing capabilities to better serve the pharmaceutical and medical device industries. CLEVELAND, Ohio – August 8, 2018 – Sotera Health, the world’s leading, fully integrated protector of global health, announced today that it has acquired New Jersey-based Gibraltar Laboratories. This …
Sotera Health Reports Second-Quarter and First-Half 2022 Results
WebSotera Health Reports Second-Quarter and First-Half 2022 Results. Aug 4, 2022. Download PDF. Q2 2022 net revenues of $267 million increased 6%, compared to Q2 2021. Q2 2022 net income of $30 million or $0.11 per diluted share, compared to net income of $43 million or $0.15 per diluted share in Q2 2021. Q2 2022 Adjusted EBITDA of $136 …
Sotera Health Appoints Karen Flynn to Board of Directors Sotera …
WebCLEVELAND, Nov. 13, 2023 (GLOBE NEWSWIRE) -- Sotera Health Company (Nasdaq: SHC), a leading global provider of mission-critical end-to-end sterilization solutions and lab testing and advisory services for the healthcare industry, announced today it has appointed Karen Flynn as a new independent director to its Board.
News Release Details
WebNew Sotera Health Academy offers curated content created by industry experts from Nelson Labs, Sterigenics, and Nordion to support MedTech and Pharmaceutical Customers CLEVELAND, March 03, 2022 (GLOBE NEWSWIRE) -- Sotera Health Company (Nasdaq: SHC), a leading global provider of mission-critical
Sotera Health Announces Fourth-Quarter and Full-Year 2023 …
WebCLEVELAND, Feb. 15, 2024 (GLOBE NEWSWIRE) -- Sotera Health Company (Nasdaq: SHC), a leading global provider of mission-critical end-to-end sterilization solutions and lab testing and advisory services for the healthcare industry, today announced its plans to release its financial results for the fourth-quarter and full-year ended December 31, 2023 …
Our Commitment to We are a global leader in our markets
WebSotera Health Company (NASDAQ: SHC) is a leading global. provider of mission-critical end-to-end sterilization solutions, lab testing and advisory services for the healthcare industry. The name Sotera Health was inspired by Soteria, the Greek goddess of safety, and reflects the Company’s unwavering commitment to its mission, Safeguarding
Sotera Health Announces Pricing of Secondary Offering Sotera …
WebCLEVELAND, Feb. 28, 2024 (GLOBE NEWSWIRE) -- Sotera Health Company (Nasdaq: SHC) (the “Company”) today announced the pricing of its secondary offering (the “Offering”) of 25,000,000 shares of its common stock, par value $0.01 per share, at a price to the public of $14.75 per share. All 25,000,000 shares are being offered by selling
Top Categories
Popular Searched
› Carthage family health center fax
› Free printable health organizers
› American home health providers corporation
› Horizon health centre weston mare
› Different global health issues
› Meritain health dispute form
› Westside urban health care center
› Healthy overweight obese weight chart
Recently Searched
› Missouri health foundation jobs
› Free printable family health charts
› West county health center patient portal
› Advanced health authorization form
› John kennedy health problems
› Conifer health prior authorization form
› Uchealth kidney transplant center
› Alternative home health lafayette la
› Book publishers for mental health books